Genentech Bio Oncology Clinical Trials

/Home/Cancer Healthcare and Treatment Centers/Clinical Trial Resources for Cancer

Genentech Bio Oncology Clinical Trials
Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080-4990

Phone: 1-650-225-1000

At Genentech, we are committed to developing therapies for unmet needs in cancer treatment. We believe that studying the biological pathways involved in cancer development, progression, and metastasis holds the key to identifying promising molecular targets. For example, this rational approach to therapeutic development allowed us to understand angiogenesis as a key process in cancer progression, identify and clone VEGF as a key mediator in angiogenesis, and develop a humanized monoclonal antibody directed at this target.

Genentech BioOncology also supports the development of clinical diagnostics to identify patients most likely to benefit from treatment with our agents. Scientists at Genentech are investigating potential diagnostic markers, including HER receptors and ligands, using a polymerase chain reaction process that may aid selection of the patients most likely to benefit from our other targeted therapies.1

The philosophy of Genentech BioOncology in focusing on both the basic biology of cancer and its application to therapeutics in oncology continues to drive our program of groundbreaking scientific discovery and the identification of novel targets and molecules for therapeutic development.

Ongoing Clinical Trials
The Clinical Trials chart provides information about current clinical trials involving Genentech BioOncology molecules.

Click on a column header in the chart to sort by that column.

Products under investigational study have not been approved by the FDA for the use under investigation. This information is presented only for purposes of providing a general overview of developmental stages and should not be construed as a recommendation for use of any product for unapproved uses.

© 2008 Genentech, Inc. All rights reserved